Abeona Therapeutics Inc. Daily Stock Analysis

Daily Stock Analysis, ABEO, Abeona Therapeutics Inc, priceseries

Abeona Therapeutics Inc. Daily Stock Analysis
Stock Information
Open
0.26
Close
0.28
High
0.28
Low
0.26
Previous Close
0.27
Daily Price Gain
0.01
YTD High
0.39
YTD High Date
Jan 4, 2022
YTD Low
0.21
YTD Low Date
Feb 24, 2022
YTD Price Change
-0.09
YTD Gain
-24.78%
52 Week High
2.41
52 Week High Date
Mar 15, 2021
52 Week Low
0.21
52 Week Low Date
Feb 24, 2022
52 Week Price Change
-1.82
52 Week Gain
-86.75%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Apr 19. 2017
5.05
May 3. 2017
5.31
10 Trading Days
5.24%
Link
LONG
Jun 21. 2017
5.00
Jul 25. 2017
8.91
23 Trading Days
78.11%
Link
LONG
Aug 23. 2017
8.75
Sep 22. 2017
14.96
21 Trading Days
71.00%
Link
LONG
Oct 10. 2017
19.95
Oct 11. 2017
21.35
1 Trading Days
7.02%
Link
LONG
Feb 6. 2018
15.95
Feb 8. 2018
17.42
2 Trading Days
9.25%
Link
LONG
Mar 1. 2018
14.00
Mar 13. 2018
15.10
8 Trading Days
7.89%
Link
LONG
Apr 9. 2018
16.55
Apr 24. 2018
18.69
11 Trading Days
12.93%
Link
LONG
Nov 22. 2019
2.58
Dec 4. 2019
3.03
7 Trading Days
17.40%
Link
LONG
Feb 14. 2020
3.17
Feb 27. 2020
3.49
8 Trading Days
10.04%
Link
LONG
Mar 31. 2020
2.10
Apr 1. 2020
2.23
1 Trading Days
5.95%
Link
LONG
May 8. 2020
2.69
May 26. 2020
3.08
11 Trading Days
14.62%
Link
LONG
Nov 10. 2020
1.15
Dec 9. 2020
1.44
20 Trading Days
24.79%
Link
LONG
Jan 19. 2021
2.14
Jan 20. 2021
2.26
1 Trading Days
5.61%
Link
LONG
Feb 2. 2021
2.03
Feb 16. 2021
2.75
9 Trading Days
35.38%
Link
LONG
Feb 25. 2021
2.49
Feb 26. 2021
2.68
1 Trading Days
7.63%
Link
LONG
Apr 30. 2021
1.77
May 4. 2021
1.91
2 Trading Days
7.63%
Link
Company Information
Stock Symbol
ABEO
Exchange
NasdaqCM
Company URL
http://www.abeonatherapeutics.com
Company Phone
2149055100
CEO
Timothy J. Miller
Headquarters
Texas
Business Address
3333 LEE PARKWAY, SUITE 600, DALLAS, TX 75219
Sector
Equity
Industry Category
Drugs
Industry Group
Biotechnology
CIK
0000318306
About

Abeona Therapeutics, Inc. operates as an emerging pharmaceutical company engaged in the development of novel therapeutics for the treatment of cancer and supportive care of cancer patients. It focuses on developing a range of pharmaceutical and medical device products primarily based upon nanopolymer chemistry technologies and other drug delivery technologies. The company's products are ProctiGard, LexaGard, CobOral and CobaCyte. Abeona Therapeutics was founded in 1974 and is headquartered in Dallas, TX.

Description

Abeona Therapeutics Inc., a biopharmaceutical company, focuses on developing and delivering gene therapy and plasma-based products for severe and life-threatening rare diseases. The company offers MuGard, a mucoadhesive oral wound rinse for mucositis, stomatitis, aphthous ulcers, and traumatic ulcers; and ProctiGard, a mucoadhesive oral wound rinse for the treatment of rectal mucositis and radiation proctitis. Its lead program is an adeno-associated virus (AAV)-based gene therapy for sanfilippo syndrome. The company develops ABO-101 for Mucopolysaccharidosis (MPS) III, a sanfilippo syndrome Type B; ABO-102 for MPS III, a sanfilippo syndrome Type A; ABO-201 for juvenile batten disease; ABO-301 for fanconi anemia; and clustered, regularly interspaced short palindromic repeats (CRISPR)-CRISPR associated protein 9 AAV for rare blood diseases. It also develops PTB-101 salt diafiltration process (SDF) Alpha, a alpha1-proteinase inhibitor for chronic augmentation and maintenance therapy in adults with clinically evident emphysema due to severe deficiency of alpha1-proteinase inhibitor; and PTB-102 SDF IVIG, an intravenous immunoglobulin for autoimmune, infectious, and idiopathic diseases. The company was formerly known as PlasmaTech Biopharmaceuticals, Inc. and changed its name to Abeona Therapeutics Inc. in June 2015. Abeona Therapeutics Inc. was incorporated in 1989 and is based in Dallas, Texas.

TCHANNELS® is a Registered Trademark with USPTO

Some images used on this site have been taken from Unsplash

Legal Information

Useful Links

Contact Us

PO Box 2574, Sunnyvale
California 94087-0574, USA
Phone: 408-940-5056
Email: Click to send us an Email

Risks of Algorithmic Trading: Before investing please read our disclosure on Risks of Algorithmic Trading.

DISCLAIMER All investments entail inherent risk. This research seeks to assist investors in determining when to buy and when to sell to attempt to maximize profits or minimize losses. All final investment decisions are yours and as a result you could make or lose money. priceSeries.com, its employees and/or its affiliates and family members may from time to time take positions in the open market or otherwise with respect to the securities discussed. priceSeries.com, its employees and/or affiliates do not have stock ownership equal to or greater than 1% of the outstanding stock of the covered company nor does any employee of priceSeries.com sit on the Board of Directors of any covered company. priceSeries.com is not a broker/dealer, and the firm does not underwrite securities, manage assets or perform investment banking activities. The statements made herein include information obtained from sources believed to be reliable, but no independent verification has been made and we do not guarantee its accuracy or completeness.

U.S. Government Required Disclaimer - Commodity Futures Trading Commission
Futures and Options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results.

CFTC RULE 4.41 - HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.

2016 © priceSeries.com All Rights Reserved. Privacy Policy | Subscriber Agreement | Risks of Algorithmic Trading